Seckin Engin1, Elif Nur Barut1, Burak Barut2, Mine Kadioglu Duman3, Cansu Kaya4, Gokcen Kerimoglu4, Arzu Ozel2. 1. Department of Pharmacology, Faculty of Pharmacy, Karadeniz Technical University, Trabzon, Turkey. 2. Department of Biochemistry, Faculty of Pharmacy, Karadeniz Technical University, Trabzon, Turkey. 3. Department of Pharmacology, Faculty of Medicine, Karadeniz Technical University, P.O:61080, Trabzon, Turkey. kadioglu20@gmail.com. 4. Department of Histology and Embryology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey.
Abstract
PURPOSE: The aim of the present study was to evaluate the potential uroprotective effect of pantoprazole (PPZ) in a mouse model of cyclophosphamide (CP)-induced hemorrhagic cystitis (HC) due to its antioxidant and anti-inflammatory properties. METHODS: Balb/c mice received a single intraperitoneal (i.p.) injection of CP (300 mg/kg) to induce HC. PPZ (20, 50, and 100 mg/kg/day;i.p.) was administered for 3 consecutive days before the induction of HC. Mesna (30 mg/kg;i.p.) was administered 20 min before, 4 and 8 h after CP injection to compare the protective effects of PPZ. After 24 h of HC induction, the bladders were removed for functional studies, biochemical analyses, and histopathological examination. RESULTS: In vitro contractility studies demonstrated that CP-induced HC decreased the responsiveness of detrusor muscle strips to acetylcholine (ACh), which was reversed by PPZ pretreatment at all doses tested. However, mesna treatment was not able to improve responsiveness to ACh. Biochemical analyses showed that CP caused significant elevation of malondialdehyde (MDA), reduction of total glutathione (GSH), and increment of proinflammatory cytokine tumor necrosis factor-alpha (TNF-α) level, which were measured in bladder homogenates. PPZ pretreatment at three doses found to be effective in reducing the CP-induced elevation of MDA and TNF-α levels. The highest dose of PPZ (100 mg/kg) caused a significant increase in GSH level. CP induced severe HC with marked bladder edema and histological disturbances which were partially abolished by PPZ pretreatment. CONCLUSIONS: Our results indicate that PPZ pretreatment could attenuate CP-induced HC by interfering with oxidative stress and modulating proinflammatory cytokines.
PURPOSE: The aim of the present study was to evaluate the potential uroprotective effect of pantoprazole (PPZ) in a mouse model of cyclophosphamide (CP)-induced hemorrhagic cystitis (HC) due to its antioxidant and anti-inflammatory properties. METHODS: Balb/c mice received a single intraperitoneal (i.p.) injection of CP (300 mg/kg) to induce HC. PPZ (20, 50, and 100 mg/kg/day;i.p.) was administered for 3 consecutive days before the induction of HC. Mesna (30 mg/kg;i.p.) was administered 20 min before, 4 and 8 h after CP injection to compare the protective effects of PPZ. After 24 h of HC induction, the bladders were removed for functional studies, biochemical analyses, and histopathological examination. RESULTS: In vitro contractility studies demonstrated that CP-induced HC decreased the responsiveness of detrusor muscle strips to acetylcholine (ACh), which was reversed by PPZ pretreatment at all doses tested. However, mesna treatment was not able to improve responsiveness to ACh. Biochemical analyses showed that CP caused significant elevation of malondialdehyde (MDA), reduction of total glutathione (GSH), and increment of proinflammatory cytokine tumor necrosis factor-alpha (TNF-α) level, which were measured in bladder homogenates. PPZ pretreatment at three doses found to be effective in reducing the CP-induced elevation of MDA and TNF-α levels. The highest dose of PPZ (100 mg/kg) caused a significant increase in GSH level. CP induced severe HC with marked bladder edema and histological disturbances which were partially abolished by PPZ pretreatment. CONCLUSIONS: Our results indicate that PPZ pretreatment could attenuate CP-induced HC by interfering with oxidative stress and modulating proinflammatory cytokines.
Authors: T Histing; D Stenger; C Scheuer; W Metzger; P Garcia; J H Holstein; M Klein; T Pohlemann; M D Menger Journal: Calcif Tissue Int Date: 2012-04-24 Impact factor: 4.333
Authors: Prashant R Gore; Chaitali P Prajapati; Umesh B Mahajan; Sameer N Goyal; Sateesh Belemkar; Shreesh Ojha; Chandragouda R Patil Journal: Int J Biol Sci Date: 2016-06-07 Impact factor: 6.580
Authors: Maximilian M Menger; Philipp Bremer; Claudia Scheuer; Mika F Rollmann; Benedikt J Braun; Steven C Herath; Marcel Orth; Thomas Später; Tim Pohlemann; Michael D Menger; Tina Histing Journal: Sci Rep Date: 2020-12-23 Impact factor: 4.379
Authors: Ayman M Mousa; Khaled S Allemailem; Fahad A Alhumaydhi; Faris Alrumaihi; Ahmad Almatroudi; Ameen S Alwashmi; Mohammad Aljasir; Osamah Al Rugaie; Abdullah S M Aljohani; Khaled E A Soliman; Mohamad Y Rezk; Ahmed M S Hegazy; Hanan S Seleem Journal: J Inflamm Res Date: 2021-11-08
Authors: Anna Merwid-Ląd; Piotr Ziółkowski; Marta Szandruk-Bender; Agnieszka Matuszewska; Adam Szeląg; Małgorzata Trocha Journal: Pharmaceuticals (Basel) Date: 2021-11-29